Also known as: ChAdOx1 nCoV-19 COVID-19 Vaccine AstraZeneca AZD1222
SARS-CoV-2 Spike glycoprotein (ChAdOx1-S) is indicated for:
Irrespective of gender only Adults (18 years old or older)
SARS-CoV-2 Spike glycoprotein (ChAdOx1-S) is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2, in individuals 18 years of age and older.
For this indication, the medical literature mentions below treatments (click for details):